<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:1248ce68-a2dc-4394-937b-d2ff93bf9ad8,g:69bd01df-5382-4e60-8807-fc4e68e35027-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CoverPage" xlink:type="simple" xlink:href="ebs-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="ebs-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_48351773-9a14-465c-a138-161992046e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_54ef2f2a-fd2e-4e5b-89d2-c1d84d3b0324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_48351773-9a14-465c-a138-161992046e9e" xlink:to="loc_us-gaap_AssetsCurrent_54ef2f2a-fd2e-4e5b-89d2-c1d84d3b0324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_970d0236-cf6e-46cf-9669-a3e60784ef6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_48351773-9a14-465c-a138-161992046e9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_970d0236-cf6e-46cf-9669-a3e60784ef6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c078b228-1e50-4dc4-8a6f-4264be0d1222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_48351773-9a14-465c-a138-161992046e9e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c078b228-1e50-4dc4-8a6f-4264be0d1222" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_InProcessResearchAndDevelopment_1095df64-5cd2-4527-91dd-78e58d3e7e6e" xlink:href="ebs-20200930.xsd#ebs_InProcessResearchAndDevelopment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_48351773-9a14-465c-a138-161992046e9e" xlink:to="loc_ebs_InProcessResearchAndDevelopment_1095df64-5cd2-4527-91dd-78e58d3e7e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0d511b70-321f-48fd-978b-060c4bcd39f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_48351773-9a14-465c-a138-161992046e9e" xlink:to="loc_us-gaap_Goodwill_0d511b70-321f-48fd-978b-060c4bcd39f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_327fb487-1c0b-4124-bb75-1a854e4a00bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_48351773-9a14-465c-a138-161992046e9e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_327fb487-1c0b-4124-bb75-1a854e4a00bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_91ddcc9b-ff55-4453-b683-c605f08ee18d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_519b1c10-dcf9-481f-8c78-dacc13843693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91ddcc9b-ff55-4453-b683-c605f08ee18d" xlink:to="loc_us-gaap_PreferredStockValue_519b1c10-dcf9-481f-8c78-dacc13843693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f6f82d8d-30a0-4cbd-a48b-4d45bf3b078c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91ddcc9b-ff55-4453-b683-c605f08ee18d" xlink:to="loc_us-gaap_CommonStockValue_f6f82d8d-30a0-4cbd-a48b-4d45bf3b078c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_138ceecb-f89d-4375-a94b-27ff0a654d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91ddcc9b-ff55-4453-b683-c605f08ee18d" xlink:to="loc_us-gaap_TreasuryStockValue_138ceecb-f89d-4375-a94b-27ff0a654d6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_96793583-66c4-4b6d-b114-c92fc7184296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91ddcc9b-ff55-4453-b683-c605f08ee18d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_96793583-66c4-4b6d-b114-c92fc7184296" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b9a5fc3-a046-41d8-9e66-04cf55167817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91ddcc9b-ff55-4453-b683-c605f08ee18d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b9a5fc3-a046-41d8-9e66-04cf55167817" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_017e5882-1bce-474b-bb45-4b03f0121d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_91ddcc9b-ff55-4453-b683-c605f08ee18d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_017e5882-1bce-474b-bb45-4b03f0121d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_10c23389-9c9c-43eb-b583-0d40f92112f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8bf0d0ba-2c0f-43bd-ae99-aa95e425a012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10c23389-9c9c-43eb-b583-0d40f92112f4" xlink:to="loc_us-gaap_AccountsPayableCurrent_8bf0d0ba-2c0f-43bd-ae99-aa95e425a012" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b4a30405-7e51-4edc-aab0-c4b69aac93bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10c23389-9c9c-43eb-b583-0d40f92112f4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b4a30405-7e51-4edc-aab0-c4b69aac93bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7647e512-c828-47e9-82b9-434af2e72198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10c23389-9c9c-43eb-b583-0d40f92112f4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7647e512-c828-47e9-82b9-434af2e72198" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_ef1305e4-d901-4ff1-b273-c5dbb4f95b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10c23389-9c9c-43eb-b583-0d40f92112f4" xlink:to="loc_us-gaap_NotesPayableCurrent_ef1305e4-d901-4ff1-b273-c5dbb4f95b6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f87868eb-0bab-4ec5-af0a-f29ca7d0c5d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10c23389-9c9c-43eb-b583-0d40f92112f4" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f87868eb-0bab-4ec5-af0a-f29ca7d0c5d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0e7a2ea3-8599-4b7f-9df9-2eef4c3be290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_001f834f-0526-4527-8901-e83055566377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0e7a2ea3-8599-4b7f-9df9-2eef4c3be290" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_001f834f-0526-4527-8901-e83055566377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_00ae6068-7942-4e1a-89a0-68a1ba07b8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0e7a2ea3-8599-4b7f-9df9-2eef4c3be290" xlink:to="loc_us-gaap_RestrictedCashCurrent_00ae6068-7942-4e1a-89a0-68a1ba07b8a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e440f5f5-a6e4-4c3c-9257-777b4c843e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0e7a2ea3-8599-4b7f-9df9-2eef4c3be290" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e440f5f5-a6e4-4c3c-9257-777b4c843e5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5f9b8bb1-a717-4b80-8411-97e96efbfb70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0e7a2ea3-8599-4b7f-9df9-2eef4c3be290" xlink:to="loc_us-gaap_InventoryNet_5f9b8bb1-a717-4b80-8411-97e96efbfb70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_53b9fb26-a954-4270-90a9-e641c0f1efca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0e7a2ea3-8599-4b7f-9df9-2eef4c3be290" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_53b9fb26-a954-4270-90a9-e641c0f1efca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2a96871a-d3e7-4e75-979e-35417bdc3f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_fb412a05-5a50-4d46-b272-a70f98decb18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2a96871a-d3e7-4e75-979e-35417bdc3f4f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_fb412a05-5a50-4d46-b272-a70f98decb18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_541ea5ed-ddf5-4359-9509-4cd2c5dc4d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2a96871a-d3e7-4e75-979e-35417bdc3f4f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_541ea5ed-ddf5-4359-9509-4cd2c5dc4d02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_49221886-a28f-4b46-ad39-0346633729aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2a96871a-d3e7-4e75-979e-35417bdc3f4f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_49221886-a28f-4b46-ad39-0346633729aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0c241b67-a699-447b-a44c-f5c57d8329c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2a96871a-d3e7-4e75-979e-35417bdc3f4f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0c241b67-a699-447b-a44c-f5c57d8329c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bb956390-545a-413c-a0d9-933999f192b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2a96871a-d3e7-4e75-979e-35417bdc3f4f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bb956390-545a-413c-a0d9-933999f192b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8b921d3a-051f-4336-97ff-080d76c3492b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2a96871a-d3e7-4e75-979e-35417bdc3f4f" xlink:to="loc_us-gaap_LiabilitiesCurrent_8b921d3a-051f-4336-97ff-080d76c3492b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_6a5f920d-6c29-44cd-bfad-a4e1d5386b82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_28d60271-c954-41f5-9e3c-f6b5f0b576dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6a5f920d-6c29-44cd-bfad-a4e1d5386b82" xlink:to="loc_us-gaap_StockholdersEquity_28d60271-c954-41f5-9e3c-f6b5f0b576dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a7ddf703-ce5a-4ba8-bb79-62dbcfe330fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_6a5f920d-6c29-44cd-bfad-a4e1d5386b82" xlink:to="loc_us-gaap_Liabilities_a7ddf703-ce5a-4ba8-bb79-62dbcfe330fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="ebs-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="ebs-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1232c72a-6c93-46d2-88e3-6b12414af57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2af6c4f2-b879-4e9a-935a-35a8914573ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1232c72a-6c93-46d2-88e3-6b12414af57d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2af6c4f2-b879-4e9a-935a-35a8914573ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fc43ac43-ae3e-4156-bf49-ba79e164c7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1232c72a-6c93-46d2-88e3-6b12414af57d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fc43ac43-ae3e-4156-bf49-ba79e164c7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_8005f138-5604-4d4a-bbef-2781db9b5e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_359f84ca-dad7-4d77-b1e2-036f8e628edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_8005f138-5604-4d4a-bbef-2781db9b5e48" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_359f84ca-dad7-4d77-b1e2-036f8e628edf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1d89412b-60a8-447e-9e22-c49bfd03dd9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_8005f138-5604-4d4a-bbef-2781db9b5e48" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1d89412b-60a8-447e-9e22-c49bfd03dd9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_96160613-6aac-466a-93a6-a65cf0f4a522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_8005f138-5604-4d4a-bbef-2781db9b5e48" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_96160613-6aac-466a-93a6-a65cf0f4a522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_76b72ba5-3e82-43ae-bf78-d7738cccb6f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_8005f138-5604-4d4a-bbef-2781db9b5e48" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_76b72ba5-3e82-43ae-bf78-d7738cccb6f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_562639d2-a3fc-4497-a2f7-66f07dd79814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3b1ea1ef-5076-4f71-ac20-4daf6527526c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_562639d2-a3fc-4497-a2f7-66f07dd79814" xlink:to="loc_us-gaap_InterestExpense_3b1ea1ef-5076-4f71-ac20-4daf6527526c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b98af432-3271-4caa-a0e0-c9097e978c02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_562639d2-a3fc-4497-a2f7-66f07dd79814" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b98af432-3271-4caa-a0e0-c9097e978c02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_104afd99-a68f-4c5d-a3bc-64756b711a1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9f793323-9aa6-4ca5-9103-f42f7c29fee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_104afd99-a68f-4c5d-a3bc-64756b711a1b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9f793323-9aa6-4ca5-9103-f42f7c29fee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_fd7f67e7-db6e-4c18-b0d8-cc7066907756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_104afd99-a68f-4c5d-a3bc-64756b711a1b" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_fd7f67e7-db6e-4c18-b0d8-cc7066907756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_193d1de5-f7d0-424f-bea4-942fb3b281bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7aff93a1-b489-442b-ab86-0be53ae9ca1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_193d1de5-f7d0-424f-bea4-942fb3b281bc" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7aff93a1-b489-442b-ab86-0be53ae9ca1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a4d30d76-a12f-4c56-8393-e5788711e107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_193d1de5-f7d0-424f-bea4-942fb3b281bc" xlink:to="loc_us-gaap_OperatingIncomeLoss_a4d30d76-a12f-4c56-8393-e5788711e107" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="ebs-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_46ed49a3-212e-4094-8bc7-7f31168cbf51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f7041c7a-cce4-46ae-ba69-1cf7aaee01db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_46ed49a3-212e-4094-8bc7-7f31168cbf51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f7041c7a-cce4-46ae-ba69-1cf7aaee01db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2db5f78a-f47e-48f3-b1e8-7372f9f97501" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_46ed49a3-212e-4094-8bc7-7f31168cbf51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2db5f78a-f47e-48f3-b1e8-7372f9f97501" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e1de1975-9d9a-43fa-bb99-27fc8fd61ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a2046975-f266-4154-8b24-9bddfcbc82ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e1de1975-9d9a-43fa-bb99-27fc8fd61ae3" xlink:to="loc_us-gaap_NetIncomeLoss_a2046975-f266-4154-8b24-9bddfcbc82ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c58db350-2672-47e7-8b66-4cfc0c20ce16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e1de1975-9d9a-43fa-bb99-27fc8fd61ae3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c58db350-2672-47e7-8b66-4cfc0c20ce16" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="ebs-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="ebs-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_467a3edf-f23e-4133-97b3-2ea1bd728a08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a54df49f-b76a-41df-8a5a-3ed0e800f7f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_467a3edf-f23e-4133-97b3-2ea1bd728a08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a54df49f-b76a-41df-8a5a-3ed0e800f7f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3625da90-ad64-40c4-9818-e4f5e7eaaf26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_467a3edf-f23e-4133-97b3-2ea1bd728a08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3625da90-ad64-40c4-9818-e4f5e7eaaf26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cf126dd-1c34-479e-8893-9b811fb019a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_467a3edf-f23e-4133-97b3-2ea1bd728a08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cf126dd-1c34-479e-8893-9b811fb019a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c012fa5c-855d-4d50-af4d-6fdd2e5a78c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_467a3edf-f23e-4133-97b3-2ea1bd728a08" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c012fa5c-855d-4d50-af4d-6fdd2e5a78c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ed4777dd-821f-4e33-b02d-2a34ef9bc137" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8a5f0596-a1c3-417b-a481-ed9ac8221304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ed4777dd-821f-4e33-b02d-2a34ef9bc137" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8a5f0596-a1c3-417b-a481-ed9ac8221304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_577dac62-9385-472c-bab1-586594ad989b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ed4777dd-821f-4e33-b02d-2a34ef9bc137" xlink:to="loc_us-gaap_RestrictedCashCurrent_577dac62-9385-472c-bab1-586594ad989b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_de321f74-d88a-46da-b0b4-ceab4c58b309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_de321f74-d88a-46da-b0b4-ceab4c58b309" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_827b2acc-f0ce-4d89-8c9d-115b41d84177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_827b2acc-f0ce-4d89-8c9d-115b41d84177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_665857fa-a11d-41ac-b704-7f1c3f874beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_665857fa-a11d-41ac-b704-7f1c3f874beb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4f961a2e-01e5-4061-b2dc-ea87d41413f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4f961a2e-01e5-4061-b2dc-ea87d41413f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ce3c39f2-8beb-455b-a387-8412799dfd91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ce3c39f2-8beb-455b-a387-8412799dfd91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ebs_ChangeInFairValueOfContingentConsideration_22a0703a-1e7f-4493-962e-3bfd7846c7dd" xlink:href="ebs-20200930.xsd#ebs_ChangeInFairValueOfContingentConsideration"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_ebs_ChangeInFairValueOfContingentConsideration_22a0703a-1e7f-4493-962e-3bfd7846c7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6cb37dca-780a-4111-8359-e1261f10db23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6cb37dca-780a-4111-8359-e1261f10db23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_38f447d7-c017-4374-a3ea-b49a966f0de9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_38f447d7-c017-4374-a3ea-b49a966f0de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e0203b80-4ab6-440e-8979-9a349667477e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e0203b80-4ab6-440e-8979-9a349667477e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_538e0d30-cbb0-44ac-a9ca-407abff39dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_538e0d30-cbb0-44ac-a9ca-407abff39dc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e9c8095c-b43e-41ba-9964-ce50562fa1ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_NetIncomeLoss_e9c8095c-b43e-41ba-9964-ce50562fa1ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_801fa51c-ebc2-444a-bad8-78721a5fee22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_801fa51c-ebc2-444a-bad8-78721a5fee22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4dc4f097-2d7b-42d5-b69f-311647e27eaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_ShareBasedCompensation_4dc4f097-2d7b-42d5-b69f-311647e27eaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_11002476-4aaa-437e-925b-d39417d9bf8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_11002476-4aaa-437e-925b-d39417d9bf8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_a5eb22e5-59e2-43e4-a9cc-cbcb7372a520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_435ff6a9-642a-4f7e-902a-646664dbae31" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_a5eb22e5-59e2-43e4-a9cc-cbcb7372a520" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b053588a-2cde-485f-903f-20957c814f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_578813a9-a10a-477f-831d-b1fe6a43cd55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b053588a-2cde-485f-903f-20957c814f4d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_578813a9-a10a-477f-831d-b1fe6a43cd55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPreviousAcquisition_6ed3f197-a683-4390-8fe1-625c0dfde366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForPreviousAcquisition"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b053588a-2cde-485f-903f-20957c814f4d" xlink:to="loc_us-gaap_PaymentsForPreviousAcquisition_6ed3f197-a683-4390-8fe1-625c0dfde366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_2ebc7833-ab42-4474-b701-961f9572facf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_2ebc7833-ab42-4474-b701-961f9572facf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_61fbc977-7920-4d36-a963-9526c2c83054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_61fbc977-7920-4d36-a963-9526c2c83054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_76d9ce7b-0dea-491e-a192-5dc3c1b94af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_76d9ce7b-0dea-491e-a192-5dc3c1b94af2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_928b2418-b178-4673-b39d-27d039e8a187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_928b2418-b178-4673-b39d-27d039e8a187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_95020676-7df6-4719-9ab7-4f6b5fd4cb41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_95020676-7df6-4719-9ab7-4f6b5fd4cb41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_02fd84d0-a846-4db4-b2b9-11496fff94c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_02fd84d0-a846-4db4-b2b9-11496fff94c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_f99eafa4-266a-4380-ab0f-f62079252e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_f99eafa4-266a-4380-ab0f-f62079252e68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_0a8f2aa3-0417-4172-96df-fad22dc143db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d91b195-4eea-40af-a13d-6cdf1a88edca" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_0a8f2aa3-0417-4172-96df-fad22dc143db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="ebs-20200930.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="simple" xlink:href="ebs-20200930.xsd#CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/CondensedConsolidatedStatementsofChangesinStockholdersEquityParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Business" xlink:type="simple" xlink:href="ebs-20200930.xsd#Business"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Business" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/BusinessDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#BusinessDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/BusinessDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/BasisofPresentationandPrinciplesofConsolidation" xlink:type="simple" xlink:href="ebs-20200930.xsd#BasisofPresentationandPrinciplesofConsolidation"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/BasisofPresentationandPrinciplesofConsolidation" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/BasisofPresentationandPrinciplesofConsolidationPolicies" xlink:type="simple" xlink:href="ebs-20200930.xsd#BasisofPresentationandPrinciplesofConsolidationPolicies"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/BasisofPresentationandPrinciplesofConsolidationPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/BasisofPresentationandPrinciplesofConsolidationDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#BasisofPresentationandPrinciplesofConsolidationDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/BasisofPresentationandPrinciplesofConsolidationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Inventoriesnet" xlink:type="simple" xlink:href="ebs-20200930.xsd#Inventoriesnet"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Inventoriesnet" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesnetTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#InventoriesnetTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesnetTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesnetDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#InventoriesnetDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c3926b1b-d595-4bc6-83c5-9844c7133e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_cab7e631-a3ea-4a0f-87b9-27984e0e8d41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c3926b1b-d595-4bc6-83c5-9844c7133e35" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_cab7e631-a3ea-4a0f-87b9-27984e0e8d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_63a61509-b281-4bfb-8edd-5bd7b37b1d8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c3926b1b-d595-4bc6-83c5-9844c7133e35" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_63a61509-b281-4bfb-8edd-5bd7b37b1d8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_44f84f61-cf0b-4db4-bee8-c7f4b5b8187d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c3926b1b-d595-4bc6-83c5-9844c7133e35" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_44f84f61-cf0b-4db4-bee8-c7f4b5b8187d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/InventoriesnetAdditionalInformationDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#InventoriesnetAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/InventoriesnetAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Propertyplantandequipment" xlink:type="simple" xlink:href="ebs-20200930.xsd#Propertyplantandequipment"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Propertyplantandequipment" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#PropertyplantandequipmentTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/PropertyplantandequipmentTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/PropertyplantandequipmentDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#PropertyplantandequipmentDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/PropertyplantandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ed2c05ed-8c80-46d0-a16d-7a47f0e81881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5f205fad-bf93-4bb7-a6cc-c3df445b5329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ed2c05ed-8c80-46d0-a16d-7a47f0e81881" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5f205fad-bf93-4bb7-a6cc-c3df445b5329" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6c602edb-0e18-4188-b669-e8404526616d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ed2c05ed-8c80-46d0-a16d-7a47f0e81881" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6c602edb-0e18-4188-b669-e8404526616d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Leases" xlink:type="simple" xlink:href="ebs-20200930.xsd#Leases"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_a34e4f84-3088-4642-8cba-3a84806fe86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5373bcd1-3a87-4d16-bdcb-27c24a982862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a34e4f84-3088-4642-8cba-3a84806fe86d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5373bcd1-3a87-4d16-bdcb-27c24a982862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_a8e1baa7-2f41-4a0e-80c9-5a528d81b7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a34e4f84-3088-4642-8cba-3a84806fe86d" xlink:to="loc_us-gaap_OperatingLeaseExpense_a8e1baa7-2f41-4a0e-80c9-5a528d81b7ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_545af766-64d2-49ec-80cd-bb5a1c5f7564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ffea3822-e0dc-4780-a655-17a103775b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_545af766-64d2-49ec-80cd-bb5a1c5f7564" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ffea3822-e0dc-4780-a655-17a103775b1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6aa4687f-1e10-4bdd-9b10-22207fe6d45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_545af766-64d2-49ec-80cd-bb5a1c5f7564" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6aa4687f-1e10-4bdd-9b10-22207fe6d45f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Intangibleassets" xlink:type="simple" xlink:href="ebs-20200930.xsd#Intangibleassets"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Intangibleassets" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#IntangibleassetsTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#IntangibleassetsScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IntangibleassetsNarrativeDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#IntangibleassetsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IntangibleassetsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Contingentconsideration" xlink:type="simple" xlink:href="ebs-20200930.xsd#Contingentconsideration"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Contingentconsideration" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ContingentconsiderationTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#ContingentconsiderationTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ContingentconsiderationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ContingentconsiderationDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#ContingentconsiderationDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ContingentconsiderationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/ContingentconsiderationFairValueLevel3ofSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#ContingentconsiderationFairValueLevel3ofSignificantUnobservableInputsDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/ContingentconsiderationFairValueLevel3ofSignificantUnobservableInputsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities" xlink:type="simple" xlink:href="ebs-20200930.xsd#Derivativeinstrumentsandhedgingactivities"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Derivativeinstrumentsandhedgingactivities" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#DerivativeinstrumentsandhedgingactivitiesTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#DerivativeinstrumentsandhedgingactivitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesDerivativeDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#DerivativeinstrumentsandhedgingactivitiesDerivativeDesignatedasCashFlowHedgesDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesDerivativeDesignatedasCashFlowHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesFairValuebyBalanceSheetLocationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DerivativeinstrumentsandhedgingactivitiesCashFlowHedgingonAOCIDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Debt" xlink:type="simple" xlink:href="ebs-20200930.xsd#Debt"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DebtTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DebtScheduleDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#DebtScheduleDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DebtScheduleDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#DebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/DebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Revenuerecognition" xlink:type="simple" xlink:href="ebs-20200930.xsd#Revenuerecognition"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Revenuerecognition" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionNarrativeDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionRemainingPerformanceObligationDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionRemainingPerformanceObligationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionRemainingPerformanceObligationDetails_1"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionDisaggregationofRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionContractLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionContractLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionPerformanceObligationsDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionPerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionPerformanceObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionPerformanceObligationsDetails_1"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#RevenuerecognitionAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/RevenuerecognitionAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8bb1f901-4911-4318-9be6-6b04cb959a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_4e6e06e0-271f-47a2-96e8-95c821790f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BilledContractReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_8bb1f901-4911-4318-9be6-6b04cb959a7f" xlink:to="loc_us-gaap_BilledContractReceivables_4e6e06e0-271f-47a2-96e8-95c821790f80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_9e496831-efd0-4320-9da2-531386de5251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_8bb1f901-4911-4318-9be6-6b04cb959a7f" xlink:to="loc_us-gaap_UnbilledContractsReceivable_9e496831-efd0-4320-9da2-531386de5251" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Incometaxes" xlink:type="simple" xlink:href="ebs-20200930.xsd#Incometaxes"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Incometaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#IncometaxesDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/IncometaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Netincomepershare" xlink:type="simple" xlink:href="ebs-20200930.xsd#Netincomepershare"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Netincomepershare" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NetincomepershareTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#NetincomepershareTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/NetincomepershareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/NetincomepershareDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#NetincomepershareDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/NetincomepershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4ab58122-8b47-4c6f-8fb6-6c5194817ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1cfa45e1-7e49-4143-8d37-ea7a8d98a885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4ab58122-8b47-4c6f-8fb6-6c5194817ec4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1cfa45e1-7e49-4143-8d37-ea7a8d98a885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2c538e6d-4b77-46f5-b4cf-06aaebbb6d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4ab58122-8b47-4c6f-8fb6-6c5194817ec4" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2c538e6d-4b77-46f5-b4cf-06aaebbb6d8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="ebs-20200930.xsd#Stockbasedcompensation"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Stockbasedcompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationTables" xlink:type="simple" xlink:href="ebs-20200930.xsd#StockbasedcompensationTables"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationNarrativeDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#StockbasedcompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/StockbasedcompensationScheduleofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ebs-20200930.xsd#StockbasedcompensationScheduleofStockbasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/StockbasedcompensationScheduleofStockbasedCompensationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="ebs-20200930.xsd#Commitmentsandcontingencies"/>
  <link:calculationLink xlink:role="http://emergentbiosolutions.com/role/Commitmentsandcontingencies" xlink:type="extended"/>
</link:linkbase>
